These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6644569)

  • 21. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier.
    Narasimhan B; Peppas NA
    J Pharm Sci; 1997 Mar; 86(3):297-304. PubMed ID: 9050796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery.
    Robitzki AA; Kurz R
    Handb Exp Pharmacol; 2010; (197):87-112. PubMed ID: 20217527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer treatment with a locally insertable controlled release delivery system.
    Keskar V; Mohanty PS; Gemeinhart EJ; Gemeinhart RA
    J Control Release; 2006 Oct; 115(3):280-8. PubMed ID: 17034891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric controlled release systems: new methods for drug delivery.
    Laurencin CT; Langer R
    Clin Lab Med; 1987 Jun; 7(2):301-23. PubMed ID: 3301172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of drug release from polymer matrices by oscillating magnetic fields.
    Edelman ER; Kost J; Bobeck H; Langer R
    J Biomed Mater Res; 1985 Jan; 19(1):67-83. PubMed ID: 4077873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release of 5-fluorouracil from ethylene acetate copolymer.
    Wyszynski RE; Vahey JB; Manning L; Bruner WE; Morgan KM; Burney EN
    J Ocul Pharmacol; 1989; 5(2):141-6. PubMed ID: 2754299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.
    Grossman SA; Reinhard C; Colvin OM; Chasin M; Brundrett R; Tamargo RJ; Brem H
    J Neurosurg; 1992 Apr; 76(4):640-7. PubMed ID: 1545259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled drug release from polymeric delivery devices IV: in vitro--in vivo correlation of subcutaneous release of norgestomet from hydrophilic implants.
    Chien YW; Lau EP
    J Pharm Sci; 1976 Apr; 65(4):488-92. PubMed ID: 1271244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
    Dashevsky A; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiomers: promising platform for macromolecular drug delivery.
    Laffleur F; Bernkop-Schnürch A
    Future Med Chem; 2012 Nov; 4(17):2205-16. PubMed ID: 23190108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release of insulin from polymer matrices. In vitro kinetics.
    Brown L; Siemer L; Munoz C; Langer R
    Diabetes; 1986 Jun; 35(6):684-91. PubMed ID: 3519323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer implants for intratumoral drug delivery and cancer therapy.
    Weinberg BD; Blanco E; Gao J
    J Pharm Sci; 2008 May; 97(5):1681-702. PubMed ID: 17847077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release in pelleted preparations as judged by urinary excretion and in vitro methods.
    SHENOY KG; CHAPMAN DG; CAMPBELL JA
    Drug Stand; 1959; 27(3):77-84. PubMed ID: 13663803
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release.
    Fulzele SV; Satturwar PM; Dorle AK
    J Pharm Sci; 2007 Jan; 96(1):132-44. PubMed ID: 16960824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets.
    Goodson JM; Holborow D; Dunn RL; Hogan P; Dunham S
    J Periodontol; 1983 Oct; 54(10):575-9. PubMed ID: 6580409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.